Berger Franklin M (CIK 0001273885)

Latest company ownership

Shares held
50,000
Last filed at
Jun 21, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
EPIX - ESSA Pharma Inc.
Role: Director
Shares held
50,000
Last filed at
Mar 28, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
40,000
Last filed at
Aug 22, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q3 2025Q4
Shares held
29,600
Last filed at
Jun 24, 2025
Confidence Score
50.1
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
7,500
Last filed at
Oct 4, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 15, 2025 Jan 17, 2025 Atea Pharmaceuticals, Inc. Director Buy 90.0 +25,000 5.53% ✗ $81.5K
Jan 15, 2025 Jan 17, 2025 Atea Pharmaceuticals, Inc. Director Sell 22.5 -25,000 -2.58% ✗ $81.5K
Dec 10, 2024 Dec 12, 2024 Atea Pharmaceuticals, Inc. Director Sell 17.5 -359,606 -44.31% ✗ $1M
Nov 21, 2023 Nov 22, 2023 ESSA Pharma Inc. Director Buy 87.5 +23,259 3.06% ✗ $133.3K
Nov 2, 2023 Nov 16, 2023 ESSA Pharma Inc. Director Buy 97.5 +76,471 11.17% ✗ $419.7K
Dec 14, 2022 Jan 5, 2023 ESSA Pharma Inc. Director Sell 20.0 -272,840 -28.50% ✗ $729.1K
Nov 11, 2022 Nov 15, 2022 Atea Pharmaceuticals, Inc. Director Sell 22.5 -41,666 -5.08% ✗ $214.7K
Mar 18, 2022 Mar 22, 2022 Kezar Life Sciences, Inc. Director Buy 95.0 +80,000 9.87% ✗ $1.3M
Feb 22, 2021 Mar 4, 2021 ESSA Pharma Inc. Director Buy 95.0 +57,000 6.33% ✗ $1.5M
Nov 3, 2020 Nov 3, 2020 Atea Pharmaceuticals, Inc. Director Buy 92.5 +41,666 5.35% ✗ $1000K
Jun 11, 2020 Jun 11, 2020 Kezar Life Sciences, Inc. Director Buy 97.5 +100,000 14.62% ✗ $550K
Feb 4, 2020 Feb 5, 2020 Kezar Life Sciences, Inc. Director Buy 97.5 +120,846 21.46% ✗ $314.2K
Jun 25, 2018 Jun 27, 2018 Kezar Life Sciences, Inc. Director Buy 92.5 +50,000 9.74% ✗ $750K
Apr 19, 2017 Apr 21, 2017 Forte Biosciences, Inc. Director Buy 97.5 +25,335 100.00% ✗ $253.4K
Aug 20, 2013 Aug 22, 2013 Lineage Cell Therapeutics, Inc. Director Buy 90.0 +500 100.00% ✗ $1.9K